AbbVie Aktie

204,50 EUR +2,00 EUR +0,99 %

15:41:14

XETRA

234,66 USD +0,79 USD +0,34 %

17:24:31

BTT

AbbVie jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.357,08 Mrd. EUR

KGV74,34Div. Rendite3,54%

WKNA1J84E

ISINUS00287Y1091

SymbolABBV

AbbVie Aktien News

Sortieren:Datum Meistgelesen

22.04.25ZacksSeeking Clues to AbbVie (ABBV) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics

22.04.25ZacksDo Options Traders Know Something About AbbVie (ABBV) Stock We Don't?

21.04.25ZacksAbbVie (ABBV) Stock Moves -1.64%: What You Should Know

20.04.25MotleyFoolIs AbbVie Stock a Buy?

18.04.25BenzingaA Congress Member Sold Up To $120K In AbbVie Stock: Here's What You Need To Know

18.04.25ZacksAbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

16.04.25ZacksThe Zacks Analyst Blog AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment

15.04.25ZacksTop Research Reports for AbbVie, TJX & Charles Schwab

15.04.25BenzingaAbbVie Options Trading: A Deep Dive into Market Sentiment

15.04.25ZacksThe Zacks Analyst Blog Merck and AbbVie

11.04.25BenzingaAbbVie Unusual Options Activity

11.04.25BenzingaEli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies

10.04.25ZacksInvestors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

10.04.25BenzingaAbbVie Stock Up 9.2% After Key Signal

08.04.25PR NewswireAbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis

03.04.25ZacksAbbVie (ABBV) Stock Moves -1.73%: What You Should Know

02.04.25ZacksAbbVie Stock Rises 16% Year to Date: Time to Buy, Sell or Hold?

31.03.25PR NewswireAbbVie to Host First-Quarter 2025 Earnings Conference Call

27.03.25ZacksAbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

26.03.25PR NewswireAbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025

24.03.25ZacksAbbVie (ABBV) Stock Sinks As Market Gains: Here's Why

24.03.25PR NewswireAllergan Aesthetics Emphasizes Commitment to Innovation, Science and a Patient Centric Approach at AMWC 2025

21.03.25BenzingaIs AbbVie Gaining or Losing Market Support?

20.03.25BenzingaAbbVie Options Trading: A Deep Dive into Market Sentiment

20.03.25MotleyFoolHere's How Many Shares of AbbVie You Need to Own to Get $1,000 in Yearly Dividends

18.03.25ZacksAbbVie (ABBV) Stock Moves -0.29%: What You Should Know

17.03.25ZacksThe Zacks Analyst Blog Highlights AbbVie, Lockheed Martin, Dell and Hamilton Beach Brands

15.03.25PR NewswireELAHERE® (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients

14.03.25ZacksTop Analyst Reports for AbbVie, Lockheed Martin & Dell

13.03.25ZacksAbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

11.03.25ZacksWhy AbbVie (ABBV) Dipped More Than Broader Market Today

10.03.25ZacksZacks Market Edge Highlights: Berkshire Hathaway, Aon plc and AbbVie

07.03.25BenzingaAbbVie Options Trading: A Deep Dive into Market Sentiment

05.03.25ZacksHere's How to Play AbbVie Stock as it Enters the Obesity Space

04.03.25Benzinga13 Analysts Have This To Say About AbbVie

04.03.25PR NewswireAbbVie to Present at the Leerink Partners Global Healthcare Conference

04.03.25PR NewswireSKYRIZI® (risankizumab) Now Available for Moderately to Severely Active Ulcerative Colitis, Expanding AbbVie's Portfolio Across Inflammatory Bowel Disease

03.03.25ZacksAbbVie (ABBV) Rises As Market Takes a Dip: Key Facts

03.03.25BenzingaAbbVie Becomes Another Big Pharma To Enter Obesity Treatment Race

03.03.25PR NewswireAbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity

AbbVie News

AbbVie News: auf dieser Seite finden Sie alle AbbVie News und Nachrichten zur AbbVie Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch AbbVie News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um AbbVie News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.